Effectiveness of national and subnational infection prevention and control interventions in high-income and upper-middle-income countries: a systematic review

The Lancet Infectious Diseases

Volumn 18, Issue 5, 2018, Pages e159-e171

  Price, Lesley ^a   MacDonald, Jennifer ^a   Melone, Lynn ^a   Howe, Tracey ^a   Flowers, Paul ^a   Currie, Kay ^a   Curran, Evonne ^a   Ness, Valerie ^a   Waddell, Debbie ^a   Manoukian, Sarkis ^a   McFarland, Agi ^a   Kilpatrick, Claire ^b   Storr, Julie ^b   Twyman, Anthony ^b   Allegranzi, Benedetta ^b   Reilly, Jacqui ^a  

^a GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARE BUNDLE; DISEASE SURVEILLANCE; EPIDEMIOLOGICAL MONITORING; EVIDENCE BASED PRACTICE; FEEDBACK SYSTEM; HEALTH CARE POLICY; HEALTH CARE QUALITY; HIGH INCOME COUNTRY; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; MIDDLE INCOME COUNTRY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGRAM EFFECTIVENESS; REVIEW; SYSTEMATIC REVIEW; WORLD HEALTH ORGANIZATION; COMMUNICABLE DISEASE CONTROL; DEVELOPING COUNTRY; ECONOMICS; HEALTH SURVEY; STANDARDS;

COMMUNICABLE DISEASE CONTROL; DEVELOPED COUNTRIES; HEALTH POLICY; HUMANS; POPULATION SURVEILLANCE; WORLD HEALTH ORGANIZATION;

EID: 85032958235     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(17)30479-6     Document Type: Review

References (74)

1. Allegranzi, B, Bagheri Nejad, S, Combescure, C, et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet 377 (2011), 228–241.
2. Bagheri Nejad, S, Allegranzi, B, Syed, SB, Ellis, B, Pittet, D, Health-care-associated infection in Africa: a systematic review. Bull World Health Organ 89 (2011), 757–765.
3. Pittet, D, Donaldson, L, Clean care is safer care: the first global challenge of the WHO world alliance for patient safety. Infect Control Hosp Epidemiol 26 (2005), 891–894.
4. ECDC. Summary: point prevalence survey of healthcare-associated infections and antimicrobial use in European hospitals 2011–2012, July 2, 2013, European Centre for Disease Prevention and Control, Stockholm https://ecdc.europa.eu/sites/portal/files/media/en/healthtopics/Healthcare-associated_infections/point-prevalence-survey/Documents/healthcare-associated-infections-antimicrobial-use-PPS-summary.pdf (accessed Oct 12, 2017).
5. Harbarth, S, Balkhy, HH, Goossens, H, et al. Antimicrobial resistance: one world, one fight!. Antimicrob Resist Infect Control, 4, 2015, 49.
6. WHO. Global action plan on antimicrobial resistance, 2015, World Health Organization, Geneva http://www.wpro.who.int/entity/drug_resistance/resources/global_action_plan_eng.pdf (accessed Oct 15, 2017).
7. WHO. Antimicrobial resistance: global report on surveillance 2014, 2014, World Health Organization, Geneva http://www.who.int/drugresistance/documents/surveillancereport/en/ (accessed May 3, 2017).
8. Zingg, W, Holmes, A, Dettenkofer, M, et al. Hospital organisation, management, and structure for prevention of health-care-associated infection: a systematic review and expert consensus. Lancet Infect Dis 15 (2015), 212–224.
9. WHO. Core components for infection prevention and control programmes, 2009, World Health Organization, Geneva http://www.who.int/csr/resources/publications/WHO_HSE_EPR_2009_1/en/ (accessed May 3, 2017).
10. WHO. Guidelines on core components of infection prevention and control programmes at the national and acute health care facility level, 2016, World Health Organization, Geneva http://www.who.int/infection-prevention/publications/core-components/en/ (accessed Oct 15, 2017).
11. Storr, J, Twyman, A, Zingg, W, et al. Core components for effective infection prevention and control programmes: new WHO evidence-based recommendations. Antimicrob Resist Infect Control, 6, 2017, 6.
12. Moher, D, Liberati, A, Tetzlaff, J, Altman, DG, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ, 339, 2009, b2535.
13. Cochrane Effective Practice and Organisation of Care. Incorporating economic evidence in EPOC reviews; EPOC resources for review authors, 2017. Cochrane Effective Practice and Organisation of Care. https://epoc.cochrane.org/sites/epoc.cochrane.org/files/public/uploads/Resources-for-authors2017/incorporating_economic_evidence_in_epoc_reviews.pdf, 2017 (accessed Oct 15,2017).
14. Cochrane Effective Practice and Organisation of Care. What study designs should be included in an EPOC review and what should they be called?; EPOC resources for review authors, 2017. Cochrane Effective Practice and Organisation of Care. http://epoc.cochrane.org/epoc-specific-resources-review-authors, 2016 (accessed May 3, 2017).
15. Shemilt, I, Mugford, M, Byford, S, et al. Specifying types of health economics studies and the scope of the economics component of a review. Higgins, JPT, Green, S, (eds.) Cochrane handbook for systematic reviews of interventions, version 5.1.0, March, 2011, The Cochrane Collaboration Chapter 15.2.3. http://handbook.cochrane.org/chapter_15/15_2_3_specifying_types_of_health_economics_studies_and_the.htm (accessed May 3, 2017).
16. Cochrane Effective Practice and Organisation of Care. Suggested risk of bias criteria for EPOC reviews. Cochrane Effective Practice and Organisation of Care. http://epoc.cochrane.org/sites/epoc.cochrane.org/files/public/uploads/Resources-for-authors2017/suggested_risk_of_bias_criteria_for_epoc_reviews.pdf, 2017 (accessed Oct 15, 2017).
17. Higgins, JPT, Altman, DG, Sterne, JA, Summary asssessments of risk of bias. Higgins, JPT, Green, S, (eds.) Cochrane handbook for systematic reviews of interventions. Version 5.1.0, March, 2011, The Cochrane Collaboration Chapter 8.7. http://handbook.cochrane.org/chapter_8/8_7_summary_assessments_of_risk_of_bias.htm (accessed May 3, 2017).
18. Guyatt, GH, Oxman, AD, Kunz, R, et al. What is “quality of evidence” and why is it important to clinicians?. BMJ 336 (2008), 995–998.
19. Guyatt, GH, Oxman, AD, Vist, GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336 (2008), 924–926.
20. Atkins, D, Best, D, Briss, PA, et al. Grading quality of evidence and strengths of recommendations. BMJ 328 (2004), 1490–1494.
21. Phillips, Z, Ginnelly, L, Schulpher, M, et al. Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health Technol Assess 8 (2004), 1–158.
22. Shemilt, I, Mugford, M, Byford, S, et al. Critical appraisal of methodological quality. Higgins, JPT, Green, S, (eds.) Cochrane handbook for systematic reviews of interventions. Version 5.1.0, March, 2011, The Cochrane Collaboration Chapter 15.5.2. http://handbook.cochrane.org/chapter_15/15_5_2_critical_appraisal_of_methodological_quality.htm (accessed May 3, 2017).
23. Shemilt, I, Mugford, M, Byford, S, et al. Narrative summary of results. 2011. Higgins, JPT, Green, S, (eds.) Cochrane handbook for systematic reviews of interventions. Version 5.1.0, March, 2011, The Cochrane Collaboration Chapter 15.6.2. http://handbook.cochrane.org/chapter_15/15_6_2_narrative_summary_of_results.htm (accessed May 3, 2017).
24. Bion, J, Richardson, A, Hibbert, P, et al. ‘Matching Michigan’: a 2-year stepped interventional programme to minimise central venous catheter-blood stream infections in intensive care units in England. BMJ Qual Saf 22 (2013), 110–123.
25. Ho, ML, Seto, WH, Wong, LC, Wong, TY, Effectiveness of multifaceted hand hygiene interventions in long-term care facilities in Hong Kong: a cluster-randomized controlled trial. Infect Control Hosp Epidemiol 33 (2012), 761–767.
26. Makris, AT, Morgan, L, Gaber, DJ, Richter, A, Rubino, JR, Effect of a comprehensive infection control program on the incidence of infections in long-term care facilities. Am J Infect Control 28 (2000), 3–7.
27. Marsteller, JA, Sexton, JB, Hsu, YJ, et al. A multicenter, phased, cluster-randomized controlled trial to reduce central line-associated bloodstream infections in intensive care units. Crit Care Med 40 (2012), 2933–2939.
28. Mody, L, Krein, SL, Saint, S, et al. A targeted infection prevention intervention in nursing home residents with indwelling devices: a randomized clinical trial. JAMA Intern Med 175 (2015), 714–723.
29. Stevenson, KB, Searle, K, Curry, G, et al. Infection control interventions in small rural hospitals with limited resources: results of a cluster-randomized feasibility trial. Antimicrob Resist Infect Control, 3, 2014, 10.
30. Yeung, WK, Tam, WS, Wong, TW, Clustered randomized controlled trial of a hand hygiene intervention involving pocket-sized containers of alcohol-based hand rub for the control of infections in long-term care facilities. Infect Control Hosp Epidemiol 32 (2011), 67–76.
31. Writing Group for the CHECKLIST-ICU Investigators and the Brazilian Research Intensive Care Network (BRICNet). Effect of a quality improvement intervention with daily round checklists, goal setting, and clinician prompting on mortality of critically ill patients: a randomized clinical trial. JAMA 315 (2016), 1480–1490.
32. Jain, R, Kralovic, SM, Evans, ME, et al. Veterans affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med 364 (2011), 1419–1430.
33. Hansen, S, Schwab, F, Schneider, S, Sohr, D, Gastmeier, P, Geffers, C, Time-series analysis to observe the impact of a centrally organized educational intervention on the prevention of central-line-associated bloodstream infections in 32 German intensive care units. J Hosp Infect 87 (2014), 220–226.
34. Newitt, S, Myles, PR, Birkin, JA, et al. Impact of infection control interventions on rates of Staphylococcus aureus bacteraemia in national health service acute hospitals, east Midlands, UK, using interrupted time-series analysis. J Hosp Infect 90 (2015), 28–37.
35. Graves, N, Page, K, Martin, E, et al. Cost-effectiveness of a national initiative to improve hand hygiene compliance using the outcome of healthcare associated Staphylococcus aureus bacteraemia. PLoS One, 11, 2016, e0148190.
36. Herzer, KR, Niessen, L, Constenla, DO, Ward, WJ Jr, Pronovost, PJ, Cost-effectiveness of a quality improvement programme to reduce central line-associated bloodstream infections in intensive care units in the USA. BMJ Open, 4, 2014, e006065.
37. Slayton, RB, Scott, RD, Baggs, J, Lessa, FC, McDonald, LC, Jernigan, JA, The cost-benefit of federal investment in preventing Clostridium difficile infections through the use of a multifaceted infection control and antimicrobial stewardship program. Infect Control Hosp Epidemiol 36 (2015), 681–687.
38. Lipitz-Snyderman, A, Steinwachs, D, Needham, DM, Colantuoni, E, Morlock, LL, Pronovost, PJ, Impact of a statewide intensive care unit quality improvement initiative on hospital mortality and length of stay: retrospective comparative analysis. BMJ, 342, 2011, d219.
39. McLaws, ML, Pantle, AC, Fitzpatrick, KR, Hughes, CF, More than hand hygiene is needed to affect methicillin-resistant Staphylococcus aureus clinical indicator rates: clean hands save lives, part IV. Med J Aust 191 (2009), S26–S31.
40. Reames, BN, Krell, RW, Campbell, DA Jr, Dimick, JB, A checklist-based intervention to improve surgical outcomes in Michigan: evaluation of the Keystone Surgery program. JAMA Surg 150 (2015), 208–215.
41. Wirtschafter, DD, Powers, RJ, Pettit, JS, et al. Nosocomial infection reduction in VLBW infants with a statewide quality-improvement model. Pediatrics 127 (2011), 419–426.
42. Bundy, DG, Gaur, AH, Billett, AL, et al. Preventing CLABSIs among pediatric hematology/oncology inpatients: national collaborative results. Pediatrics 134 (2014), e1678–e1685.
43. Miller, MR, Griswold, M, Harris, JM 2nd, et al. Decreasing PICU catheter-associated bloodstream infections: NACHRI's quality transformation efforts. Pediatrics 125 (2010), 206–213.
44. Miller, MR, Niedner, MF, Huskins, WC, et al. Reducing PICU central line-associated bloodstream infections: 3-year results. Pediatrics 128 (2011), e1077–e1083.
45. Schweizer, ML, Chiang, HY, Septimus, E, et al. Association of a bundled intervention with surgical site infections among patients undergoing cardiac, hip, or knee surgery. JAMA 313 (2015), 2162–2171.
46. Lee, GM, Kleinman, K, Soumerai, SB, et al. Effect of nonpayment for preventable infections in U.S. hospitals. N Engl J Med 367 (2012), 1428–1437.
47. Schuller, K, Probst, J, Hardin, J, Bennett, K, Martin, A, Initial impact of Medicare's nonpayment policy on catheter-associated urinary tract infections by hospital characteristics. Health Policy 115 (2014), 165–171.
48. Schwaber, MJ, Lev, B, Israeli, A, et al. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 52 (2011), 848–855.
49. Marsteller, JA, Hsu, YJ, Weeks, K, Evaluating the impact of mandatory public reporting on participation and performance in a program to reduce central line-associated bloodstream infections: evidence from a national patient safety collaborative. Am J Infect Control 42:suppl 10 (2014), S209–S215.
50. Schmier, JK, Hulme-Lowe, CK, Semenova, S, et al. Estimated hospital costs associated with preventable health care-associated infections if health care antiseptic products were unavailable. Clinicoecon Outcomes Res 8 (2016), 197–205.
51. Robotham, JV, Deeny, SR, Fuller, C, Hopkins, S, Cookson, B, Stone, S, Cost-effectiveness of national mandatory screening of all admissions to English National Health Service hospitals for meticillin-resistant Staphylococcus aureus: a mathematical modelling study. Lancet Infect Dis 16 (2016), 348–356.
52. Fuller, C, Michie, S, Savage, J, et al. The Feedback Intervention Trial (FIT)—improving hand-hygiene compliance in UK healthcare workers: a stepped wedge cluster randomised controlled trial. PLoS One, 7, 2012, e41617.
53. McKinley, LL, Moriarty, HJ, Short, TH, Johnson, CC, Effect of comparative data feedback on intensive care unit infection rates in a Veterans Administration Hospital Network System. Am J Infect Control 31 (2003), 397–404.
54. WHO. Guide to Implementation: a guide to the implementation of the WHO multimodal hand hygiene improvement strategy, 2009, World Health Organization, Geneva http://www.who.int/gpsc/5may/Guide_to_Implementation.pdf (accessed May 3, 2017).
55. Resar, R, Pronovost, P, Haraden, C, Simmonds, T, Rainey, T, Nolan, T, Using a bundle approach to improve ventilator care processes and reduce ventilator-associated pneumonia. Jt Comm J Qual Patient Saf 31 (2005), 243–248.
56. Albertini, MT, Benoit, C, Berardi, L, et al. Surveillance of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae producing extended-spectrum β-lactamase (ESBLE) in Northern France: a five-year multicentre incidence study. J Hosp Infect 52 (2002), 107–113.
57. Carbonne, A, Arnaud, I, Maugat, S, et al. National multidrug-resistant bacteria (MDRB) surveillance in France through the RAISIN network: a 9 year experience. J Antimicrob Chemother 68 (2013), 954–959.
58. Gastmeier, P, Geffers, C, Brandt, C, et al. Effectiveness of a nationwide nosocomial infection surveillance system for reducing nosocomial infections. J Hosp Infect 64 (2006), 16–22.
59. Jurke, A, Kock, R, Becker, K, et al. Reduction of the nosocomial meticillin-resistant Staphylococcus aureus incidence density by a region-wide search and follow-strategy in forty German hospitals of the EUREGIO, 2009 to 2011. Euro Surveill, 18, 2013 pii 20579.
60. Kanerva, M, Mentula, S, Virolainen-Julkunen, A, et al. Reduction in Clostridium difficile infections in Finland, 2008–2010. J Hosp Infect 83 (2013), 127–131.
61. Astagneau, P, L'Hériteau, F, Daniel, F, et al. Reducing surgical site infection incidence through a network: results from the French ISO-RAISIN surveillance system. J Hosp Infect 72 (2009), 127–134.
62. Rioux, C, Grandbastien, B, Astagneau, P, Impact of a six-year control programme on surgical site infections in France: results of the INCISO surveillance. J Hosp Infect 66 (2007), 217–223.
63. Marchi, M, Pan, A, Gagliotti, C, et al. The Italian national surgical site infection surveillance programme and its positive impact, 2009 to 2011. Euro Surveill, 19, 2014 pii 20815.
64. Palumbo, AJ, Loveless, PA, Moll, ME, Ostroff, S, Evaluation of healthcare-associated infection surveillance in Pennsylvania hospitals. Infect Control Hosp Epidemiol 33 (2012), 105–111.
65. Dixon-Woods, M, Bosk, CL, Aveling, EL, Goeschel, CA, Pronovost, PJ, Explaining Michigan: developing an ex post theory of a quality improvement program. Milbank Q 89 (2011), 167–205.
66. The Health Foundation. Infection prevention and control: lessons from acute care in England, 2015, The Health Foundation, London http://www.health.org.uk/publication/infection-prevention-and-control-lessons-acute-care-england (accessed May 3, 2017).
67. Stone, SP, Fuller, C, Savage, J, et al. Evaluation of the national Cleanyourhands campaign to reduce Staphylococcus aureus bacteraemia and Clostridium difficile infection in hospitals in England and Wales by improved hand hygiene: four year, prospective, ecological, interrupted time series study. BMJ, 344, 2012, e3005.
68. Michie, S, Prestwich, A, Are interventions theory-based? Development of a theory coding scheme. Health Psychol 29 (2010), 1–8.
69. Michie, S, Richardson, M, Johnston, M, et al. The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions. Ann Behav Med 46 (2013), 81–95.
70. Borg, MA, Lowbury lecture 2013. Cultural determinants of infection control behaviour: understanding drivers and implementing effective change. J Hosp Infect 86 (2014), 161–168.
71. De Bono, S, Heling, G, Borg, MA, Organizational culture and its implications for infection prevention and control in healthcare institutions. J Hosp Infect 86 (2014), 1–6.
72. von Elm, E, Altman, DG, Egger, M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335 (2007), 806–808.
73. Schulz, KF, Altman, DG, Moher, D, CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ, 340, 2010, c332.
74. Ogrinc, G, Davies, L, Goodman, D, Batalden, P, Davidoff, F, Stevens, D, SQUIRE 2·0 (Standards for Quality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process. Am J Crit Care 24 (2015), 466–473.